I was simply talking about innocent until proven guilty

New Post Public Reply Private Reply Replies (0) Message Board
Figgs craigakess #131976
492
I was simply talking about innocent until proven guilty thing, and I would never say I like or dislike someone personally on a board like this, never, because it detracts from actual points. Well, I take that back, Adam Feuerstein can go to hell and not collect the $200.

What I do dislike is some of your comments. You do not know if BP has approached us this past year but backed off until we are clear of the hold or because of this investigation.
You also under estimate the intelligence of members of this board. There were those of us who thought that a known huckster might actually get us an EUA in spite of BP.

As for conspiracy theories, some of us are more well read than that. The NYTimes has been reporting since 2019 about the FDA drug approval division being 75% funded by Big Pharma. The Opioid crisis found rampant corruption between the two agencies. In a trial of NP and KK crap could come out.

NYTimes
By Christina Jewett
Sept. 15, 2022

Every five years, top officials of the Food and Drug Administration go behind closed doors to negotiate the terms of its core budget — about $3 billion this year.

But the F.D.A. is not at the table with members of Congress or with White House officials. Instead, it’s in dozens of meetings with representatives of the giant pharmaceutical companies whose products the agency regulates. The negotiations are a piece of the “user fee” program in which drug, device and biotech companies make payments to the agency partly to seek product approvals. The fees have soared since the program’s inception three decades ago and now make up nearly half of the F.D.A.’s budget, financing 6,500 jobs at the agency.

The pharmaceutical industry funding alone has become so dominant that last year it accounted for three-quarters — or $1.1 billion — of the agency’s drug division budget.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zimmer Biomet's Financial Commitment to Investors with New Dividend

Updated Category News Views 109

Zimmer Biomet's Dividend Announcement Today, Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a leading name in the medical technology industry, shared some exciting news regarding its commitment to rewarding investors. The company's Board of Directors has approved the payment of a quarterly cash dividend, continuing its aim to deliver value to stockholders. Details of...

Continue Reading
Keysight Technologies Enhances Chiplet Design Solutions for 2025

Updated Category News Views 167

Keysight Technologies Launches Chiplet PHY Designer 2025 Keysight Technologies, Inc. (NYSE: KEYS) has unveiled its latest innovation, the Chiplet PHY Designer 2025, aimed at advancing high-speed digital chiplet designs specifically tailored for AI and data center applications. This new solution enhances simulation capabilities by supporting the Universal Chiplet...

Continue Reading
Key Insights into Tenet Healthcare Corp Stock Trends and Sentiment

Updated Category News Views 162

Understanding Recent Market Sentiments Surrounding Tenet Healthcare Tenet Healthcare Corp (NYSE: THC) has seen a notable uptick in short interest as a percentage of its float, having increased by 3.2% since the last report. Currently, there are approximately 2.55 million shares sold short, which translates to about 3.87% of all shares available for trading. This uptick...

Continue Reading
Investing in the Autonomous Vehicle Revolution: Key Stocks

Updated Category News Views 260

Autonomous Vehicles: A Reality Autonomous vehicles (AVs) have transitioned from mere concepts to practical applications as they gain traction in various sectors worldwide. This industry, estimated to be worth $1.2 trillion, is being revolutionized by advancements in artificial intelligence that are reshaping how transportation operates. Bank of America recently...

Continue Reading
Casino Group's Transformative Renouveau 2030 Financial Strategy

Updated Category News Views 207

Casino Group's Initiative for Financial Strengthening Casino Group has embarked on an ambitious journey to adapt and strengthen its financial structure through the Renouveau 2030 plan. This initiative reflects the company's commitment to enhancing its operational capabilities while managing its debts effectively. With the support of France Retail Holdings (FRH), which...

Continue Reading